These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 32634346

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Acute fatal myocarditis after a single dose of anti-PD-1 immunotherapy, autopsy findings: a case report.
    Hardy T, Yin M, Chavez JA, Ivanov I, Chen W, Nadasdy T, Brodsky SV.
    Cardiovasc Pathol; 2020; 46():107202. PubMed ID: 32062109
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Complete response of renal cell carcinoma vena cava tumor thrombus to neoadjuvant immunotherapy.
    Labbate C, Hatogai K, Werntz R, Stadler WM, Steinberg GD, Eggener S, Sweis RF.
    J Immunother Cancer; 2019 Mar 11; 7(1):66. PubMed ID: 30857555
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Nivolumab plus ipilimumab in advanced renal-cell carcinoma.
    Gunjur A.
    Lancet Oncol; 2018 May 11; 19(5):e232. PubMed ID: 29606588
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Immune-Related Adverse Events Involving Multiple Organ Sites in a Patient Treated With Nivolumab Plus Ipilimumab.
    Remolina-Bonilla YA, Jimenez-Franco B, Lam ET, Bourlon MT.
    Oncology (Williston Park); 2020 May 13; 34(5):171-174. PubMed ID: 32644176
    [Abstract] [Full Text] [Related]

  • 16. Fatal enteric plexus neuropathy after one dose of ipilimumab plus nivolumab: a case report.
    Appelbaum J, Wells D, Hiatt JB, Steinbach G, Stewart FM, Thomas H, Nghiem P, Kapur RP, Thompson JA, Bhatia S.
    J Immunother Cancer; 2018 Aug 31; 6(1):82. PubMed ID: 30170630
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Sequential immune-targeted surgical therapy resulted in disease-free survival in a case with advanced renal cell carcinoma.
    Nishimura K, Miura N, Sugihara N, Funaki K, Koyama K, Sawada Y, Noda T, Fukumoto T, Miyauchi Y, Kikugawa T, Saika T, Matsumura M, Hashine K, Taniwaki M.
    BMC Urol; 2021 Sep 08; 21(1):124. PubMed ID: 34496819
    [Abstract] [Full Text] [Related]

  • 19. Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.
    Motzer RJ, Tannir NM, McDermott DF, Arén Frontera O, Melichar B, Choueiri TK, Plimack ER, Barthélémy P, Porta C, George S, Powles T, Donskov F, Neiman V, Kollmannsberger CK, Salman P, Gurney H, Hawkins R, Ravaud A, Grimm MO, Bracarda S, Barrios CH, Tomita Y, Castellano D, Rini BI, Chen AC, Mekan S, McHenry MB, Wind-Rotolo M, Doan J, Sharma P, Hammers HJ, Escudier B, CheckMate 214 Investigators.
    N Engl J Med; 2018 Apr 05; 378(14):1277-1290. PubMed ID: 29562145
    [Abstract] [Full Text] [Related]

  • 20. Widespread subacute cutaneous lupus erythematosus in a patient receiving checkpoint inhibitor immunotherapy with ipilimumab and nivolumab.
    Kosche C, Owen JL, Choi JN.
    Dermatol Online J; 2019 Oct 15; 25(10):. PubMed ID: 31735010
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.